Literature DB >> 19026156

Mortality in Behçet's syndrome.

H Yazici1, F Esen.   

Abstract

Behçet's syndrome significantly increases mortality especially when seen in the young male, while it is less severe among females and the aged. In many patients, the condition abates with the passage of time. The main cause of mortality is large vessel disease, especially bleeding pulmonary artery aneurysms (PAA), almost exclusively seen among men. Central nervous system disease comes second. Interestingly, not much increased atherosclerosis is seen in Behçet's syndrome when compared to other inflammatory diseases. In controlled studies, there has been no increase in history of increased angina or myocardial infarction. Similarly, atherosclerotic plaque formation is not increased by ultrasound. On the other hand, intermittent claudication can be seen. However, this is not due to arterial involvement but due to venous disease of the lower extremities. Recently there has been a substantial decrease in mortality due to PAA thanks to prompt disease recognition and treatment.

Entities:  

Mesh:

Year:  2008        PMID: 19026156

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  13 in total

1.  Carotid artery stiffness in Behçet's disease.

Authors:  Servet Yolbaş; Nevzat Gözel; Mustafa Necati Dağlı; Süleyman Serdar Koca; Emir Dönder
Journal:  Eur J Rheumatol       Date:  2017-06-01

Review 2.  Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.

Authors:  Rosaria Talarico; Laura Palagini; Anna d'Ascanio; Elena Elefante; Claudia Ferrari; Chiara Stagnaro; Chiara Tani; Angelo Gemignani; Mauro Mauri; Stefano Bombardieri; Marta Mosca
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

3.  Development of de novo major involvement during follow-up in Behçet's syndrome.

Authors:  Rosaria Talarico; Luca Cantarini; Anna d'Ascanio; Michele Figus; Benedetta Favati; Chiara Baldini; Chiara Tani; R Neri; Stefano Bombardieri; Marta Mosca
Journal:  Clin Rheumatol       Date:  2015-03-08       Impact factor: 2.980

Review 4.  Behcet's disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature.

Authors:  Menghui Yao; Congcong Gao; Chunyi Zhang; Xueqi Di; Wenfang Liang; Wenbo Sun; Qianqian Wang; Zhaohui Zheng
Journal:  Rheumatol Int       Date:  2020-07-16       Impact factor: 2.631

5.  Massive hemoptysis and deep venous thrombosis presenting in a woman with Hughes-Stovin syndrome: a case report.

Authors:  Hamdan Al-Jahdali
Journal:  J Med Case Rep       Date:  2010-04-21

Review 6.  Behçet's disease and comorbidity: internal case reports and literature review.

Authors:  Zemfira Alekberova; Vadim Gorodetskiy; Fatima Izmailova; Stefka Radenska-Lopovok; Elnura Talybova; Margarita Evsikova; Nikolai Timoshin; Evgeni Nasonov
Journal:  Rheumatol Int       Date:  2015-02-13       Impact factor: 2.631

7.  Mortality associated with Behçet's disease in France assessed by multiple-cause-of-death analysis.

Authors:  Emmanuelle David; Mathieu Fauvernier; David Saadoun; Mathieu Gerfaud-Valentin; Delphine Maurcort-Boulch; Pascal Sève; Yvan Jamilloux
Journal:  Clin Rheumatol       Date:  2022-01-29       Impact factor: 2.980

8.  Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement.

Authors:  Agnès Hamzaoui; Hanene Chelbi; Fayçal Hai Sassi; Kamel Hamzaoui
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

Review 9.  Hughes-Stovin syndrome.

Authors:  Umair Khalid; Taimur Saleem
Journal:  Orphanet J Rare Dis       Date:  2011-04-13       Impact factor: 4.123

10.  Behçet's disease presenting with Budd-Chiari syndrome and intracardial thrombus: a case report.

Authors:  Minji Jennifer Kim; Yong Suk Jo; Jee Hyun Kim; Yong-Jin Kim; Kyung Hwan Kim; Eun Bong Lee; Yeong Wook Song; Eun Young Lee
Journal:  Int Med Case Rep J       Date:  2011-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.